Murray patent opposition analysis

The comprehensive analysis of Murray opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Murray

Patent NumberTitleApplicantOpposition DateOpposition Company
Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla GeneAMICUS THERAPEUTICS, INC.Aug 5, 2026BRAND MURRAY FULLER
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIM INTERNATIONAL GMBHAug 3, 2026BRAND MURRAY FULLER SERVICES
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS, INC.Jul 29, 2026BRAND MURRAY FULLER
Reference Beads For Linking Imaging And Sequencing Readouts With Single-Cell ResolutionBECTON, DICKINSON AND COMPANYJul 29, 2026BRAND MURRAY FULLER
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL-MYERS SQUIBB COMPANYJul 28, 2026BRAND MURRAY FULLER
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECA ABJun 16, 2026BRAND MURRAY FULLER
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICS, INC.Jun 3, 2026BRAND MURRAY FULLER
Degarelix Drug ProductFERRING B.V.Jun 1, 2026ACCORD HEALTHCARE SLU
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISK A/SMay 5, 2026ZENTIVA
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICS, INC.Apr 15, 2026BRAND MURRAY FULLER